The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best pharma stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) received a rating ...

President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...

Sanofi (SNY) and AstraZeneca (AZN) stocks are in focus as FDA to review their infant RSV treatments following safety concerns ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

The U.S. Centers for Disease Control and Prevention (CDC) recommends Beyfortus or Enflonsia for babies younger than 8 months ...

U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of ...

The agency also is reviewing safety of immunizations for RSV, according to manufacturers of the therapies who have been ...